Masaru Katoh

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 218 publications

Antibody-drug conjugates targeting the cadherin, claudin and nectin families of adhesion molecules.

Antibody-drug conjugates targeting the cadherin, claudin and nectin families of adhesion molecules.

Journal: Frontiers in molecular medicine

Published: July 07, 2025

Claudin 1, 4, 6 and 18 isoform 2 as targets for the treatment of cancer (Review).

Claudin 1, 4, 6 and 18 isoform 2 as targets for the treatment of cancer (Review).

Journal: International journal of molecular medicine

Published: July 24, 2024

Monoclonal antibodies that target fibroblast growth factor receptor 2 isoform b and Claudin-18 isoform 2 splicing variants in gastric cancer and other solid tumours.

Monoclonal antibodies that target fibroblast growth factor receptor 2 isoform b and Claudin-18 isoform 2 splicing variants in gastric cancer and other solid tumours.

Journal: Clinical and translational medicine

Published: May 23, 2024

FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions.

FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions.

Journal: Nature reviews. Clinical oncology

Published: February 06, 2024

Activated FGFR2 signalling as a biomarker for selection of intrahepatic cholangiocarcinoma patients candidate to FGFR targeted therapies.

Activated FGFR2 signalling as a biomarker for selection of intrahepatic cholangiocarcinoma patients candidate to FGFR targeted therapies.

Journal: Scientific reports

Published: August 29, 2023

WNT signaling and cancer stemness.

WNT signaling and cancer stemness.

Journal: Essays in biochemistry

Published: June 09, 2022

Grand Challenges in Molecular Medicine for Disease Prevention and Treatment Through Cyclical Innovation.

Grand Challenges in Molecular Medicine for Disease Prevention and Treatment Through Cyclical Innovation.

Journal: Frontiers in molecular medicine

Published: June 04, 2021

Precision medicine for human cancers with Notch signaling dysregulation (Review).

Precision medicine for human cancers with Notch signaling dysregulation (Review).

Journal: International journal of molecular medicine

Published: September 16, 2019

CD157 and CD200 at the crossroads of endothelial remodeling and immune regulation.

CD157 and CD200 at the crossroads of endothelial remodeling and immune regulation.

Journal: Stem cell investigation

Published: March 11, 2019

Genomic testing, tumor microenvironment and targeted therapy of Hedgehog-related human cancers.

Genomic testing, tumor microenvironment and targeted therapy of Hedgehog-related human cancers.

Journal: Clinical science (London, England : 1979)

Published: January 14, 2019

Combination immuno-oncology therapy with pembrolizumab, an anti-PD-1 monoclonal antibody targeting immune evasion, and standard chemotherapy for patients with the squamous and non-squamous subtypes of non-small cell lung cancer.

Combination immuno-oncology therapy with pembrolizumab, an anti-PD-1 monoclonal antibody targeting immune evasion, and standard chemotherapy for patients with the squamous and non-squamous subtypes of non-small cell lung cancer.

Journal: Journal of thoracic disease

Published: November 13, 2018

Fibroblast growth factor receptors as treatment targets in clinical oncology.

Fibroblast growth factor receptors as treatment targets in clinical oncology.

Journal: Nature reviews. Clinical oncology

Published: October 28, 2018

Showing 1-12 of 218

Last Updated: 09/26/2026